Gujarat Kidney & Super Speciality Ltd
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
- Market Cap ₹ 806 Cr.
- Current Price ₹ 102
- High / Low ₹ 123 / 100
- Stock P/E 85.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 51.5 %
- ROE 51.2 %
- Face Value ₹ 2.00
Pros
- Debtor days have improved from 229 to 138 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0.00 | 4.77 | 40.24 | |
| 0.01 | 2.81 | 23.68 | |
| Operating Profit | -0.01 | 1.96 | 16.56 |
| OPM % | 41.09% | 41.15% | |
| 0.00 | 0.70 | 0.15 | |
| Interest | 0.00 | 0.07 | 0.65 |
| Depreciation | 0.00 | 0.32 | 3.29 |
| Profit before tax | -0.01 | 2.27 | 12.77 |
| Tax % | 0.00% | 24.67% | 25.53% |
| -0.01 | 1.71 | 9.50 | |
| EPS in Rs | -0.50 | 85.50 | 1.66 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 744% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 697% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 51% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 11.37 |
| Reserves | 0.17 | 10.60 | 14.57 |
| 0.00 | 5.86 | 8.31 | |
| 3.50 | 3.86 | 21.09 | |
| Total Liabilities | 3.87 | 20.52 | 55.34 |
| 0.00 | 13.64 | 31.01 | |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| 3.87 | 6.88 | 24.33 | |
| Total Assets | 3.87 | 20.52 | 55.34 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0.00 | 1.21 | 13.61 | |
| 0.00 | 0.22 | -18.14 | |
| 0.00 | -0.47 | 6.16 | |
| Net Cash Flow | 0.00 | 0.97 | 1.63 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 321.38 | 137.51 | |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 321.38 | 137.51 | |
| Working Capital Days | 100.24 | -24.13 | |
| ROCE % | 19.26% | 51.52% |
Documents
Announcements
- Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026 13m
-
Closure of Trading Window
2d - Trading window closed from 1 Jan 2026 until 48 hours after December quarter unaudited results declaration.
- Listing of Equity Shares of Gujarat Kidney and Super Speciality Ltd 30 Dec
Annual reports
No data available.
Business Profile[1]
Gujarat Kidney and Super Speciality Limited is a regional healthcare operator in central Gujarat, running a chain of mid-sized multi-speciality hospitals focused on secondary and tertiary care.